Single-use bioreactors are advanced bioreactors designed for single-use applications in biopharmaceutical manufacturing. They offer various advantages such as reduced risk of cross-contamination, lower capital investment, lower cleaning and validation costs, and improved process flexibility. Single-use bioreactors find wide applications in the production of monoclonal antibodies, vaccines, stem cells, insect cells, and plant cell culture. They help minimize operation costs and time to market by streamlining cell culture processes. The global single-use bioreactor market is estimated to be valued at US$ 1337.67 Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing adoption of single-use bioreactors in biopharmaceutical manufacturing is a key driver fueling the market growth. Rising demand for biologics and growing biopharmaceutical industry have necessitated improved manufacturing technologies like single-use bioreactors. Their advantages over traditional stainless steel bioreactors such as lower capital costs, reduced operation costs, easy installation and process optimization are boosting their adoption rates. However, challenges pertaining to extractable and leachables from single-use components need to be addressed carefully for ensuring safety of biopharmaceutical products. Ongoing technological advancements in single-use bioreactor systems focusing on safety, automation, and connectivity are estimated to offer lucrative opportunities over the forecast period.
SWOT Analysis
Strength: Single-use bioreactors offer increased cost savings compared to traditional stainless steel bioreactors. They minimize capital expenditure and operational costs as there is no requirement of cleaning and sterilization after each batch production. Single-use bioreactors can be easily installed and replaced, thereby reducing process downtime.
Weakness: Limited reusability of single-use components leads to increased material costs over time. Additionally, lack of technical support for custom configurations is another drawback.
Opportunity: Growing need for cost-effective and flexible manufacturing processes across industries like pharmaceuticals and biopharmaceuticals is fueling demand for single-use bioreactors. Increasing investments in cell culture-based research is also opening up opportunities.
Threats: Stringent regulations pertaining to the material composition and leachables may limit the application scope. Risk of product contamination due to product contact remains a challenge.
Key Takeaways
The global Single-Use Bioreactor Market Demand is expected to witness high growth over the forecast period 2023 to 2030 on account of rapid expansion of the biopharmaceutical sector. Regionally, North America dominated the market in 2023 with over 35% share owing to robust government support and presence of key players. Growth rates are estimated higher in Asia Pacific as countries like China and India emerge as major hubs for biopharma companies to outsource manufacturing.
Key players operating in the single-use bioreactor market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. These companies are focusing on capacity expansion and new product launches to consolidate their market position. For instance, Sartorius AG recently inaugurated a new single-use system manufacturing facility in Maine to support significant capacity increases for the North American market.
The global single-use bioreactor market is expected to witness high growth over the forecast period 2023 to 2030 on account of rapid expansion of the biopharmaceutical sector. Regionally, North America dominated the market in 2023 with over 35% share owing to robust government support and presence of key players. Growth rates are estimated higher in Asia Pacific as countries like China and India emerge as major hubs for biopharma companies to outsource manufacturing.
Get more insights on this topic: https://www.pressreleasebulletin.com/single-use-bioreactor-market-growth-demand-and-overview/
Comments
0 comment